Hangzhou Alltest Biotech Co (SHSE:688606) ROCE % : 8.75% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Alltest Biotech Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hangzhou Alltest Biotech Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 8.75%.

Hangzhou Alltest Biotech Co ROCE % Historical Data

The historical data trend for Hangzhou Alltest Biotech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Alltest Biotech Co ROCE % Chart

Hangzhou Alltest Biotech Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

33.15

128.31

41.99

37.00

4.96

Hangzhou Alltest Biotech Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															4.04	8.69	4.92	9.61	8.75

Hangzhou Alltest Biotech Co ROCE % Calculation

Hangzhou Alltest Biotech Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	198.898	/	( ( (4694.822 - 510.753)	+	(4116.058 - 274.163) )	/ 2 )
	=	198.898	/	( (4184.069	+	3841.895)	/ 2 )
	=	198.898	/	4012.982
	=	4.96 %

Hangzhou Alltest Biotech Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	337.096	/	( ( (4179.337 - 362.226)	+	(4164.664 - 274.295) )	/ 2 )
	=	337.096	/	( ( 3817.111	+	3890.369 )	/ 2 )
	=	337.096	/	3853.74
	=	8.75 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Hangzhou Alltest Biotech Co (SHSE:688606) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hangzhou Alltest Biotech Co ROCE % Related Terms

Thank you for viewing the detailed overview of Hangzhou Alltest Biotech Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Alltest Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hangzhou Alltest Biotech Co Ltd (SHSE:688606) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 550, Yinhai Street, Baiyang Street, Hangzhou Economic and Technological Development Zone, Building 3-5, Zhejiang Province, Hangzhou, CHN, 310018

Website

http://www.alltests.com.cn

Hangzhou Alltest Biotech Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents.

Executives

Fu Yan Ping	senior management
Lu Wei Ke	Directors, senior managers, core technical personn
Gao Fei	Directors, senior managers, core technical personn

Hangzhou Alltest Biotech Co Headlines

No Headlines